To Pool, Pledge, or License – Allocating IP Rights during COVID-19 R&D
As the biotech industry rapidly mobilized its resources to tackle the COVID-19 pandemic, voices from various sectors advocated for a number of approaches to ensure that researchers could access patented technology quickly, with minimal transaction costs and without fear of infringement liability. This webinar will feature differing perspectives on the various models for allocating patent rights among researchers and collaborators, and among public and private entities in various technology sectors. The panelists will discuss practical business considerations, the benefits of simplified licensing arrangements, and the potential risks and benefits for patent owners and potential licensees alike.
Featuring:
- Brenda Herschbach Jarrell, Practice Group Leader, Life Sciences and Intellectual Property, Choate Hall & Stewart LLP (Moderator)
- Jorge L. Contreras, Professor, S.J Quinney College of Law, the University of Utah
- Rahul K. Dhanda, Co-Founder, Chief Executive Officer, President & Director, Sherlock Biosciences
- Irene Pleasure, Senior Vice President and General Counsel, Vir Biotechnology, Inc.
- Dick Wilder, General Counsel and Head of Business Development, Coalition for Epidemic Preparedness Initiative
Sponsored By Choate Hall & Stewart LLP
